Browse by category

Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 agonist drugs...

Individuals who take liraglutide or semaglutide for weight loss reduced their alcohol consumption by almost two-thirds in four months,...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with...

Women are much more aware of and knowledgeable about the obesity drugs GLP-1/GIP receptor agonists (that include semaglutide and...

First generation weight-loss medications like liraglutide and exenatide appear to show anti-cancer benefits beyond weight loss. Indeed,...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) may help to reduce the risk of heart attacks, strokes, and other major adverse...

A Monell Chemical Senses Center study has identified that GLP-1 receptor agonists as a promising therapeutic for managing the metabolic...

Investigators from Mass General Brigham who examined claims data from nearly two million people between 2021 and 2023, have reported a...

Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of the...

A research team from the School of Public Health, in the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), who assessed...